Skip to main content

The Harvard Drug Group

No ongoing recalls currently shown

Based on the official records currently available to Public Health Trace, no recalls naming The Harvard Drug Group are currently shown as ongoing. The 45 records below are historical recall records.

Public Health Trace has 45 recalls naming The Harvard Drug Group as the recalling firm, republished from official FDA and USDA sources.

Recall history - 45 terminated records

Recalls by year

A bar chart of the number of recalls naming this company by year.

Recalls by year
YearRecalls
20161
201726
20209
20214
20222
20233
Download CSV

FDA Recall TerminatedTerminated: April 30, 2024Historical recordClass II

Tramadol Hydrochloride Tablets, USP 50 mg, Unit Dose 100-Count Tablets Rx only, Manufactured by: Sun Pharmaceutical Industries Ltd. Survey No. 259/15, Dadra-396 191, (U.T. of D & NH), India. Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Distributed by: Major Pharmaceuticals Livonia, MI 48152 USA, NDC 0904-7179-61

by The Harvard Drug Group

Reason
Packaging defect: blister packaging inadequately sealed.
Published
July 5, 2023
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: April 30, 2024Historical recordClass III

Gabapentin Tablets, USP 600 mg, packaged in Cartons of 100 tablets (10 tablets per blister pack x 10), Rx Only, Distributed by: Aurobindo Pharma USA, Inc. East Windsor, NJ 08520 Distributed by: Major Pharmaceuticals 17177 N Laurel Park Dr., Suite 233 Livonia, MI 48152 USA, NDC 0904-6823-61

by The Harvard Drug Group

Reason
Product mixup: one foreign tablet found in product.
Published
May 17, 2023
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: April 30, 2024Historical recordClass II

Carbidopa and Levodopa Tablets, USP 25 mg/100 mg, 10x10 Unit Dose carton, Rx Only, Manufactured in Czech Republic by: Teva Czech Industries, s.r.o. Opava-Komarov, Czech Republic, Manufactured for: Teva Pharmaceuticals USA, Inc. Parsippany, NJ 07054, Packaged and Distributed by: Major Pharmaceuticals Indianapolis, IN 46268 USA. NDC 0904-7257-61, UPC 3 09047 25761 4

by The Harvard Drug Group

Reason
Packaging defect: observed packaging defect, blister packaging inadequately sealed.
Published
March 8, 2023
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: July 16, 2023Historical recordClass II

hydrALAZINE HCl Tablets, USP, 10 mg, 100 Tablets per carton (10x10 blister packs), Rx only, Distributed by: MAJOR PHARMACEUTICALS, Livonia, MI 48152 USA. NDC # 0904-6440-61

by The Harvard Drug Group

Reason
Failed Impurities/Degradation Specifications: Out of specification result obtained during routine stability testing for Impurities.
Published
March 23, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: June 8, 2023Historical recordClass II

PALIPERIDONE EXTENDED-RELEASE TABLETS, 9 mg, 100 Tablets per carton (10 x 10 blister packs), Rx only, Manufactured by: Sun Pharmaceutical Industries Ltd., Survey No. 259/15, Dadra-396 191, India. Distributed by: MAJOR PHARMACEUTICALS, 17177 N. Laurel Park Dr., Suite 233, Livonia, MI 48152. NDC: 0904-6937-61

by The Harvard Drug Group

Reason
Failed Dissolution Specifications
Published
March 16, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: July 16, 2023Historical recordClass II

Fexofenadine Hydrochloride Tablets, 60 mg, 500 Tablets per bottle, Distributed by: Major Pharmaceuticals, 17177 N. Laurel Park Drive, Suite 233, Livonia, MI 48152 NDC 0904-6979-40

by The Harvard Drug Group

Reason
Failed Impurities/Degradation Specifications
Published
December 29, 2021
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: November 8, 2022Historical recordClass II

Carbamazepine 200mg Tablets, USP, 200 mg, 100 Count Unit Dose Cartons, Rx only, Manufactured by: Torrent Pharmaceuticals Ltd., Bharuch-392130, India; Manufactured for: Torrent Pharma, Inc., Basking Ridge, NJ 07920; Distributed by: MAJOR PHARMACEUTICALS, 17177 N. Laurel Park Dr., Suite 233, Livonia, MI 48152 USA. NDC 0904-6172-61

by The Harvard Drug Group

Reason
Failed Dissolution Specifications
Published
September 29, 2021
Distribution
NC

View recall →

FDA Recall TerminatedTerminated: February 19, 2023Historical recordClass II

Entacapone Tablets, USP, 200 mg, Rx only, 30 Tablets per unit dose cartons, Distributed by: Major Pharmaceuticals, 17177 N. Laurel Park Dr., Suite 233, Livonia, MI 48152. NDC 0904-6822-04

by The Harvard Drug Group

Reason
Failed Dissolution Specifications
Published
September 29, 2021
Distribution
Multiple states

View recall →

FDA Recall TerminatedTerminated: December 28, 2022Historical recordClass II

NIFEdipine EXTENDED-RELEASE TABLETS, USP 30 mg Rx only packaged as a) 100 count unit dose carton, NDC 0904-7080-61; b) 50 count unit dose carton, NDC 0904-7080-06: Distributed by: Ingenus Pharmaceuticals, LLC Orlando, FL 32839-6408 Distributed by: Major Pharmaceuticals 17177 N Laurel Park Dr., Suite 233 Livonia, MI 48152 USA

by The Harvard Drug Group

Reason
Failed Dissolution Specification: Out of specification for dissolution during routine stability testing.
Published
July 21, 2021
Distribution
Distributed in OH and NJ

View recall →

FDA Recall TerminatedTerminated: February 19, 2023Historical recordClass II

Aripiprazole Tablets, USP, 15 mg, 30 tablets per unit dose carton, Rx Only, Manufactured by: Apotex, Inc, Toronto, Ontario Canada M9L 1T9, Distributed by: Major Pharmaceuticals, 17177 N. Laurel Park Dr., Suite 233, Livonia, MI 48152 USA, NDC 0904-6512-04

by The Harvard Drug Group

Reason
Failed Dissolution Specifications: Out of specification for dissolution.
Published
December 9, 2020
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 24, 2022Historical recordClass II

Metformin Hydrochloride Extended-Release Tablets, USP, 500 mg, 100 Tablets (10 x 10) unit dose cartons, Rx only, Manufactured by: Apotex, Inc., Toronto, Ontario, Canada, Manufactured for: Apotex Corp. Weston, FL, Distributed by: Major Pharmaceuticals, Livonia, MI 48152 NDC 00904-5794-61

by The Harvard Drug Group

Reason
CGMP Deviation: Potential presence of Nitrosodimethylamine (NDMA) Impurity above the established levels.
Published
July 8, 2020
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: October 2, 2022Historical recordClass II

Doxycycline Hyclate Tablets, USP, 100 mg, packaged in a) 3x10 unit dose cartons (NDC 0904-0430-04) and b) 5 x 10 unit dose carton (NDC 0904-0430-06), Mfd. by: West-Ward Pharmaceutical Corp., Eatontown, NJ 07724; Distributed by: Major Pharmaceuticals, 17177 N. Laurel Park Dr., Suite 233, Livonia, MI 48152.

by The Harvard Drug Group

Reason
Failed Dissolution Specification: The dissolution test at the 24 month time point (end of shelf life) yielded an out-of-specification result.
Published
June 10, 2020
Distribution
Nationwide

View recall →

Some FDA recall records on this page come from FDA's Enforcement Report database. Not every Enforcement Report record has a separate FDA.gov recall-announcement page.

This page lists recalls that name The Harvard Drug Group as the recalling firm in the official source notice. It is not a safety rating, ranking, or statement that the company acted negligently. Read the full medical disclaimer.

Reconnecting to the server…

We lost the connection to the server.

Your session has expired.